S2013: I-CHECKIT ***Upcoming Temporary Closure 5/6/24 @ 2pm CST***

Study Number: S2013: I-CHECKIT ***Upcoming Temporary Closure 5/6/24 @ 2pm CST***

Please Note:

This study examines how certain risk factors (such as age, gender, other medical conditions, and the type of immunotherapy used to treat the cancer) affect whether a patient with a malignant solid tumor will develop mild or serious side effects from the immunotherapy medications. Immunotherapy is the type of treatment that helps the body's immune system fight cancer. In the future, this information may help doctors make better decisions about cancer treatments.

Available Sites

• Missouri Baptist Medical Center

Contact Person(s)

• MBMC, Henry Robinson, 314-996-5865

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.